title: Results of the phase III trials with Imagent GI as an oral magnetic resonance contrast agent.
authors.affiliation: University of California, San Diego.
authors.forename: R F
authors.initials: RF
authors.lastname: Mattrey
authors.forename: M A
authors.initials: MA
authors.lastname: Trambert
authors.forename: J J
authors.initials: JJ
authors.lastname: Brown
authors.forename: J N
authors.initials: JN
authors.lastname: Bruneton
authors.forename: S W
authors.initials: SW
authors.lastname: Young
authors.forename: G L
authors.initials: GL
authors.lastname: Schooley
mesh_terms: D000284:Administration, Oral; D000328:Adult; D002986:Clinical Trials as Topic; D003287:Contrast Media / Q000008:administration & dosage; D004655:Emulsions; D005466:Fluorocarbons / Q000008:administration & dosage; D005767:Gastrointestinal Diseases / Q000175:diagnosis*; D006801:Humans; D006842:Hydrocarbons, Brominated; D008279:Magnetic Resonance Imaging / Q000379:methods*
chemical_list: D003287:Contrast Media; D004655:Emulsions; D005466:Fluorocarbons; D006842:Hydrocarbons, Brominated; C003072:perflubron